News & Analysis on Clinical Trial Services & Contract Research And Development
Agilent's purchase of DowPharma's Nucleic Acid Medicines business is the second time in recent years that the US scientific measurements specialist has ramped-up its nucleic acid manufacturing capabilities.
China is on course to having its own version of the International Pharmaceutical Excipients Council - joining its fellow organisations in Europe, the Americas and Japan.
Switzerland-based Schweizerhall appears to have circumnavigated patent law, with approval of its generic version of Bristol-Myers Squibb's (BSM) and Sanofi-Aventis' Plavix (clopidogrel bisulfate) in Germany "expected shortly".
In-PharmaTechnologist's periodic round-up of events in the pharmaceutical excipient space includes one product launch and two regulatory developments.
Canada-based Biovail has revealed plans to close two Puerto Rican manufacturing plants and lay off 250 people as it attempts to cut costs.
Weekly comment
2005 marked the real beginning of contract manufacturing in Japan, which had been held back by an overly-cautious regulatory environment and significant and unique quality and specification demands in the marketplace.
Outsourcing-Pharma.com compiles the news that has featured in the clinical contract community of late, involving Tigermed Consulting, Lifetree Clinical Research, Synexus and Anapharm.